AVBP EPS Estimates
ArriVent BioPharma, Inc. Common Stock
$14.16
+$0.52(+3.81%)
36
Overall
60
Value
27
Tech
21
Quality
Market Cap
$672.56M
Volume
803.72K
52W Range
$11.36 - $35.83
Target Price
$26.73
AVBP EPS estimates: the consensus estimate for ArriVent BioPharma, Inc. Common Stock's current fiscal year is -$4.04 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AVBP EPS Estimates
- EPS estimate, current quarter
- $-1.04
- EPS estimate, next quarter
- $-1.03
- EPS estimate, current year
- $-4.04
- EPS estimate, next year
- $-3.48
- EPS growth, 3-year
- -1100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.32 |
| 2024 | $-2.56 |
| 2022 | $-0.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVBP | $14.16 | +3.8% | 803.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ArriVent BioPharma, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW